Management of Patients with Left Ventricular Assist Device during the COVID-19 Pandemic

Gassan Moady*, Tuvia Ben Gal, Shaul Atar

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

The novel coronavirus disease 2019 (COVID-19) is an infectious disease with multi-organ involvement, including the cardiovascular system. The disease may cause several cardiovascular complications, and may increase morbidity and mortality among patients with background cardiovascular disease. Patients with advanced heart failure are often treated with left ventricular assist device (LVAD), and represent a unique population mandating multi-disciplinary approach. Several aspects of COVID-19 should be taken into account in LVAD implants, including right ventricular involvement, hemodynamic alterations, thromboembolic and haemorrhagic complications, and the psychological effects of social isolation. Patients with VAD and suspected COVID-19 should be transferred to specialized centers for better management of complications. Here, we review the implications of COVID-19 pandemic on LVAD patients with our recommendations for appropriate management.

Original languageEnglish
Article number116
JournalMedicina (Lithuania)
Volume58
Issue number1
DOIs
StatePublished - Jan 2022

Keywords

  • Coronavirus disease
  • Heart failure
  • Ventricular assist device

Fingerprint

Dive into the research topics of 'Management of Patients with Left Ventricular Assist Device during the COVID-19 Pandemic'. Together they form a unique fingerprint.

Cite this